Sunil Sharma
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 17
- Histone Deacetylase Inhibitors Research 16
- Oncology 50
- Colorectal Cancer Treatments and Studies 19
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Hariprasad Vankayalapati (8 shared papers)Steven L. Warner (9 shared papers)David J. Bearss (8 shared papers)Arvinder Kaur (14 shared papers)Owias Iqbal Dar (12 shared papers)Kapil N. Bhalla (16 shared papers)Anupam Verma (5 shared papers)Venkataswamy Sorna (6 shared papers)
- Journals
- Journal of Clinical Oncology (32 papers)Cancer Research (14 papers)Cancer Chemotherapy and Pharmacology (12 papers)Blood (11 papers)Molecular Cancer Therapeutics (11 papers)
- Partner nations
- United StatesIndiaSwitzerland
In The Last Decade
Sunil Sharma
133 papers receiving 3.8k citations
Sunil Sharma's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.3k
- Hematology 393
- Immunology 527
- Molecular Biology 1.7k
- Pulmonary and Respiratory Medicine 486
Countries citing papers authored by Sunil Sharma
This map shows the geographic impact of Sunil Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Sharma more than expected).
Fields of papers citing papers by Sunil Sharma
This network shows the impact of papers produced by Sunil Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Sharma. The network helps show where Sunil Sharma may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunil Sharma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer Hit paper breakdown → | 2016 | 663 |
| 2 | 2006 | 264 | |
| 3 | 2011 | 180 | |
| 4 | 2013 | 163 | |
| 5 | 2014 | 157 | |
| 6 | 2021 | 137 | |
| 7 | 2014 | 131 | |
| 8 | 2014 | 125 | |
| 9 | 2014 | 112 | |
| 10 | 2015 | 85 | |
| 11 | 2000 | 84 | |
| 12 | 2018 | 79 | |
| 13 | 2011 | 76 | |
| 14 | 2020 | 65 | |
| 15 | 2013 | 48 | |
| 16 | 2014 | 48 | |
| 17 | 2013 | 47 | |
| 18 | 2005 | 47 | |
| 19 | 2021 | 44 | |
| 20 | 2014 | 44 |
About Sunil Sharma
Sunil Sharma is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Immunology, having authored 140 papers that have together received 3.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Protein Degradation and Inhibitors (17 papers), Histone Deacetylase Inhibitors Research (16 papers), Lung Cancer Treatments and Mutations (15 papers), Multiple Myeloma Research and Treatments (14 papers), Pharmaceutical and Antibiotic Environmental Impacts (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (1.3k citations), Hematology (393 citations), Immunology (527 citations), Molecular Biology (1.7k citations) and Pulmonary and Respiratory Medicine (486 citations). Sunil Sharma has collaborated with scholars based in United States, India and Switzerland. Frequent co-authors include Hariprasad Vankayalapati, Steven L. Warner, David J. Bearss, Arvinder Kaur, Owias Iqbal Dar, Kapil N. Bhalla, Anupam Verma, Venkataswamy Sorna, Michael S. Gordon and Emily R. Theisen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Chemotherapy and Pharmacology, Blood and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.